Hu8F4 in Treating Patients With Advanced Hematologic Malignancies

Clinical trial NCT02530034 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02530034
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Hematopoietic and Lymphoid Cell Neoplasm High Risk Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome With Excess Blasts-2 Myelofibrosis Recurrent Acute Myeloid Leukemia Recurrent Chronic Myelomonocytic Leukemia Refractory Chronic Myelomonocytic Leukemia Secondary Acute Myeloid Leukemia

Start date: 2019-01-31
Primary completion: 2027-01-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.